Device for detecting gene mutation and kit for genotyping pregnant women and fetuses
一种基因型、试剂盒的技术,应用在生物信息领域,能够解决父亲来源遗传信息依赖限制、增加测序成本、全基因组测序测序深度要求高等问题
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0187] Example 1 A method for detecting gene mutations
[0188] Experiment 1: Sample acquisition and cell-free DNA extraction
[0189] (1) Place the isolated peripheral blood of pregnant women in a centrifuge, centrifuge at a speed of 1600g for 10 minutes, and then absorb the plasma.
[0190] (2)(2) Obtain the isolated peripheral plasma of pregnant women, and use the kit QIAamp DNA Blood Mini Kit (Qiagen, Germany, catlog#51106) to extract the free DNA in the plasma. The method is the blood and body fluid processing method in the kit .
[0191] Experiment 2: Capture enrichment and library construction
[0192] 2.1 End repair of cell-free DNA in plasma of pregnant women
[0193] Purpose of the experiment: Since the cell-free DNA extracted from the plasma of pregnant women is double-stranded DNA fragments, these fragments are either blunt-ended or contain 3' or 5' overhanging ends. This step phosphorylates the overhangs to blunt ends by T4 DNA polymerase, E. coli DNA polymera...
Embodiment 2
[0315] Example 2 is an example of non-invasive monogenic disease diagnosis in fetuses with osteogenesis imperfecta
[0316] Sample information: 28-year-old pregnant woman, 3 times of pregnancy and 0 deliveries, regular menstruation, 5-6 days of menstrual period, 29 days of menstrual cycle. Last menstrual period 2012-03-27, expected date of delivery 2013-01-04. Naturally conceived, no history of fever, rash, etc. during early pregnancy, and no history of exposure to radiation poisons. Toxoplasma gondii, rubella, giant cell, and herpes simplex virus were all negative at 13 weeks of pregnancy, B-ultrasonography at 14+ weeks of pregnancy measured the width of fetal neck thickness zona pellucida (NT) was 0.14cm, and serological screening at 17+ weeks of pregnancy showed the risk of trisomy 21< 1:50000, the risk of trisomy 18 <1:50000. B-ultrasound at the health care hospital at 26+ weeks of pregnancy revealed abnormal development of the femur and tibia of the fetus, and re-examin...
Embodiment 3
[0321] Embodiment 3 is the verification of the false tetraploid typing model of the present invention
[0322]For the above-mentioned venous blood samples of pregnant women, the false tetrad typing model of the present invention is used for detection and analysis, and at the same time, the somatic cell detection method of "fetal umbilical cord blood sample + maternal peripheral blood sample" is used for verification to evaluate the method of the present invention. Validity of pseudo-tetraploid typing models.
[0323] Combining the results of somatic cell sequencing of pregnant women and the results of somatic cell sequencing of umbilical cord blood samples, compared with the results of pseudo-tetraploid typing, the results of pseudo-tetraploid typing are shown in Table 5, which is compared with the somatic cell sequencing of pregnant women in the prior art The accuracy rate of the results compared with the somatic cell sequencing results of umbilical cord blood samples is show...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com